Skip to main content

Advertisement

Table 2 Demographics of recipients included in this study

From: Donation after brain death followed by circulatory death, a novel donation pattern, confers comparable renal allograft outcomes with donation after brain death

Clinical Values DBCD (n = 383) DBD (n = 140) P
Age(years) 42.5 ± 11.1 43.1 + 11.6 0.85
Gender (%Female) 37.6 32.1 0.26
Preoperative Cr(μmol/L) 931.2 ± 287.4 1033.6 ± 324 0.06
Previous transplants, n (%)
 First transplant 374(97.7) 135(96.4) 0.54
 Second transplant 9(2.3) 5(3.6)
PRA, n (%)
  < 10% 371(96.9) 135(96.4) 0.78
 10–50% 12(3.1) 5(3.6)
Induction therapy, n (%)
 antithymocyte globulin 291(76) 39(27.9) 0
 basiliximab 92(24) 101(72.1)
HLA mismatches, n (%)
 0–1 274(71.5) 106(75.7) 0.22
 2–4 79(20.6) 29(20.7)
 5–6 30 (7.9) 5(3.6)
  1. Cr creatinine, PRA panel-reactive antibody, HLA human leukocyte antigen